siRNA Therapy

Search documents
Sarepta Therapeutics(SRPT) - 2025 Q1 - Earnings Call Transcript
2025-05-06 21:32
Sarepta Therapeutics (SRPT) Q1 2025 Earnings Call May 06, 2025 04:30 PM ET Company Participants Mary Jenkins - Senior Manager of Investor RelationsDouglas Ingram - President & CEODallan Murray - EVP & Chief Customer OfficerLouise Rodino-Klapac - Executive Vice President, Head of R&D and Chief Scientific OfficerIan Estepan - EVP & CFOTazeen Ahmad - MD - US Equity ResearchLouise Chen - Managing DirectorAndrew Tsai - SVPBrian Abrahams - MD & Global Sector Head - Health Care ResearchDebjit Chattopadhyay - Manag ...
Silence Therapeutics PLC(SLN) - 2024 Q4 - Earnings Call Transcript
2025-02-28 16:59
Gem Hopkins Good morning and good afternoon, everyone. Thank you for joining us today. My name is Gem Hopkins, Vice President of Investor Relations and Corporate Communications at Silence. Joining me on today’s call are Craig Tooman, our President and CEO, who will provide an update on the business; Rhonda Hellums, our Chief Financial Officer, who will review our financial performance; and Steven Romano, our Chief R&D Officer, who will provide a clinical update. For those of you participating via conference ...
Sarepta Therapeutics(SRPT) - 2024 Q4 - Earnings Call Transcript
2025-02-27 04:48
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Mary Jenkins - Associate Director, Investor Relations and Corporate Communications Doug Ingram - President and CEO Ian Estepan - Executive Vice President and CFO Dallan Murray - Executive Vice President and CCO Dr. Louise Rodino-Klapac - Executive Vice President, Chief Scientific Officer and Head, Research & Development Conference Call Participants Tazeen Ahmad - Bank of America Securi ...